Orocidin and Syngene Forge Alliance to Propel Biotech Innovation and GMP Peptide Development

Unknown Apr 02, 2026 1,700 Views

Orocidin A/S, wholly owned subsidiary of Nordicus Partners (OTCQB: NORD), has entered into a strategic partnership with Syngene International to advance GMP peptide development pipelines. The two firms will focus on the development of Orocidin's QR-01, leveraging Syngene's scalable and co...

Stay Ahead – Explore Now! NLC India Secures Telangana Mineral Block in Strategic Expansion